ADMP:NASDAQ

is a specialty biopharmaceutical company focused on developing and commercializing products for opioid overdose and respiratory and inflammatory disease. 

This is a play that I found off of Tim Sykes Watchlists. Here’s what he had to say. 

“ADMP reports earnings after the close on Monday along with having a PDUFA date of November 15th for their opioid abuse drug. On their earnings call, the company will most likely give a trial update on their Covid-19 drug”. 

ADMP gapped up over the weekend and crapped at the market open for a panic dip buy opportunity. This might be able to re-spike but probably not a good hold overnight as this could be a buy the rumor sell the news situation.